CF
Cantor Fitzgerald Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
176
Capricor Therapeutics
CAPR
$290M
|
KK
Kristen Kluska
| $6.48 | $30 |
363%
upside
| Overweight |
14 May ‘25
3 months ago |
|
177
Pharvaris
PHVS
$1.4B
|
TI
Timur Ivannikov
| $23.94 | $25 |
4%
upside
| Overweight |
14 May ‘25
3 months ago |
|
178
SoundThinking
SSTI
$156M
|
JR
Jonathan Ruykhaver
| $11.99 | $20 |
67%
upside
| Overweight |
14 May ‘25
3 months ago |
|
179
Astria Therapeutics
ATXS
$419M
|
TI
Timur Ivannikov
| $7.53 | $47 |
524%
upside
| Overweight |
14 May ‘25
3 months ago |
|
180
Vanda Pharmaceuticals
VNDA
$269M
|
OB
Olivia Brayer
| $4.51 | $13 |
188%
upside
| Overweight |
14 May ‘25
3 months ago |
|
181
Neuropace
NPCE
$321M
|
RO
Ross Osborn
| $9.97 | $17 |
71%
upside
| Overweight |
14 May ‘25
3 months ago |
|
182
Applied Materials
AMAT
$129B
|
CJM
C J Muse
| $163.50 | $200 |
22%
upside
| Overweight |
12 May ‘25
4 months ago |
|
183
Vera Therapeutics
VERA
$1.58B
|
PS
Pete Stavropoulos
| $25.08 | $100 |
299%
upside
| Overweight |
7 May ‘25
4 months ago |
|
184
Advanced Micro Devices
AMD
$246B
|
MP
Matthew Prisco
| $155.82 | $120 |
23%
downside
| Overweight |
7 May ‘25
4 months ago |
|
185
Xometry
XMTR
$2.63B
|
TJ
Troy Jensen
| $49.84 | $21 |
58%
downside
| Underweight |
7 May ‘25
4 months ago |
|
186
Sarepta Therapeutics
SRPT
$1.84B
|
KK
Kristen Kluska
| $17.64 | $81 |
359%
upside
| Overweight |
7 May ‘25
4 months ago |
|
187
Rivian
RIVN
$17B
|
AS
Andres Sheppard
| $13.94 | $15 |
8%
upside
| Neutral |
7 May ‘25
4 months ago |
|
188
Humana
HUM
$37.3B
|
SJ
Sarah James
| $273.02 | $290 |
6%
upside
| Neutral |
1 May ‘25
4 months ago |
|
189
Qualcomm
QCOM
$173B
|
MP
Matthew Prisco
| $158.66 | $150 |
5%
downside
| Neutral |
1 May ‘25
4 months ago |
|
190
Booking.com
BKNG
$181B
|
DM
Deepak Mathivanan
| $5,571.83 | $4,440 |
20%
downside
| Neutral |
30 Apr ‘25
4 months ago |
|
191
Wave Life Sciences
WVE
$1.21B
|
SS
Steven Seedhouse
| $7.48 | $10 |
34%
upside
| Overweight |
29 Apr ‘25
4 months ago |
|
192
Korro Bio
KRRO
$309M
|
SS
Steven Seedhouse
| $36.12 | $74 |
105%
upside
| Overweight |
29 Apr ‘25
4 months ago |
|
|
193
Pharvaris
PHVS
$1.4B
|
SS
Steven Seedhouse
| $23.94 | $28 |
17%
upside
| Overweight |
29 Apr ‘25
4 months ago |
|
194
Apellis Pharmaceuticals
APLS
$3.4B
|
EM
Eliana Merle
| $26.84 | $44 |
64%
upside
| Overweight |
29 Apr ‘25
4 months ago |
|
|
195
Astria Therapeutics
ATXS
$419M
|
SS
Steven Seedhouse
| $7.53 | $47 |
524%
upside
| Overweight |
29 Apr ‘25
4 months ago |
|
196
InflaRx
IFRX
$107M
|
SS
Steven Seedhouse
| $1.53 | $10 |
554%
upside
| Overweight |
29 Apr ‘25
4 months ago |
|
197
BioCryst Pharmaceuticals
BCRX
$1.72B
|
SS
Steven Seedhouse
| $8.08 | $20 |
148%
upside
| Overweight |
29 Apr ‘25
4 months ago |
|
198
Viking Therapeutics
VKTX
$2.87B
|
SS
Steven Seedhouse
| $25.27 | $104 |
312%
upside
| Overweight |
28 Apr ‘25
4 months ago |
|
199
Taysha Gene Therapies
TSHA
$884M
|
KK
Kristen Kluska
| $3.28 | $7 |
113%
upside
| Overweight |
28 Apr ‘25
4 months ago |
|
200
NXP Semiconductors
NXPI
$56.9B
|
CJM
C J Muse
| $223.69 | $225 |
1%
upside
| Overweight |
28 Apr ‘25
4 months ago |
|